PLEASE NOTE: Recorded webinars and sessions are not applicable for CE credits.
Oral Appliance Therapy for Sleep Apnea: Treatment Planning using MATRx plus
Oral Appliance Therapy (OAT) is a growing treatment option for people suffering from obstructive sleep apnea (OSA); however, this therapy does have its challenges and limitations. During this webinar, you will hear about a practical, evidence-based solution that will increase OAT’s efficacy and improve patient care. The basis for OSA treatment planning is MATRx plus™, an auto-titrating at-home sleep testing device, that delivers reliable and predictable results, leads to higher case acceptance and better patient experience. In addition, you will learn how the use of MATRx plus will improve the relationship between the dental and medical communities and drive patient referrals.
1. To understand the limitations of current methods for implementing oral appliances in treating sleep apnea
2. To review the evidence and utility of MATRx plus in treatment planning
3. To set the stage for positive interactions with physicians
As the Chief Medical Officer (CMO) and co-founder of Zephyr Sleep Technologies, Dr. John Remmers leads the research, design, and development of innovative sleep products used in the diagnoses and treatment of obstructive sleep apnea. He is a recognized physiologist, pioneer, and innovator in sleep medicine.
As a world-renowned expert in the field of snoring and obstructive sleep apnea, Dr. Remmers has published over one hundred peer reviewed articles in the area of respiratory physiology. Over the past decade, Dr. Remmers has dedicated his research to patient selection for oral appliance therapy, which led to the development of the MATRx plus, an auto-titrating mandibular positioning testing device.
He holds a Bachelor of Medicine and a Bachelor of Physiology from Dartmouth Medical School. Dr. Remmers has also completed his Pre-Doctoral Fellowship from the Harvard Medical School and completed his Post-Doctoral Fellowship at Dartmouth Medical School.